Syros Pharmaceuticals Newsroom

TD Cowen Maintains Syros Pharmaceuticals(SYRS.US) With Hold Rating

Futu NewsNov 13 21:35

HC Wainwright & Co. Downgrades Syros Pharmaceuticals to Neutral, Lowers Price Target to $1

BenzingaNov 13 19:55

Syros Pharmaceuticals Cut to Market Perform From Market Outperform by JMP Securities

Dow JonesNov 13 19:04

Syros Pharmaceuticals Analyst Ratings

BenzingaNov 13 18:42

JMP Securities Downgrades Syros Pharmaceuticals(SYRS.US) to Hold Rating

Futu NewsNov 13 14:31

TD Cowen Downgrades Syros Pharmaceuticals(SYRS.US) to Hold Rating

Futu NewsNov 13 11:31

Brookline Capital Downgrades Syros Pharmaceuticals(SYRS.US) to Hold Rating

Futu NewsNov 13 10:32

Syros Pharmaceuticals Analyst Ratings

BenzingaNov 1 19:22

H.C. Wainwright Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 1 18:36

TD Cowen Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating

Futu NewsNov 1 00:32

JMP Securities Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating, Cuts Target Price to $4

Futu NewsOct 31 22:32

Piper Sandler Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating, Cuts Target Price to $5

Futu NewsOct 23 20:31

Piper Sandler Remains a Buy on Syros Pharmaceuticals (SYRS)

TipRanksOct 23 19:46

Syros Pharmaceuticals Price Target Cut to $4.00/Share From $12.00 by JMP Securities

Dow JonesAug 13 20:08

TD Cowen Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating

Futu NewsAug 13 19:33

Piper Sandler Keeps Their Buy Rating on Syros Pharmaceuticals (SYRS)

TipRanksAug 13 18:58

HC Wainwright & Co. Maintains Buy on Syros Pharmaceuticals, Lowers Price Target to $6

BenzingaAug 13 18:57

Syros Pharmaceuticals Analyst Ratings

BenzingaAug 13 18:57

H.C. Wainwright Maintains Syros Pharmaceuticals(SYRS.US) With Buy Rating, Cuts Target Price to $6

Futu NewsAug 13 18:31

Syros Pharmaceuticals Analyst Ratings

BenzingaAug 1 21:12